comparemela.com

Page 12 - Piramal Group News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Piramal Alternatives invests Rs 110 crore in Biodeal Pharmaceuticals

Piramal Alternatives invested Rs 110 crore in Noida-based Biodeal Pharmaceuticals through convertible instruments. The funding will enhance infrastructure, technology, and a nutraceuticals manufacturing facility. Biodeal is a key contract manufacturing player, specializing in nasal sprays and achieving PIC/S approval.

Anurag kumarKalpesh kikaniBiodeal pharmaceuticalsPiramal groupCredit fundPiramal enterprises etmarketsPiramal enterprisesNoida based biodeal pharmaceuticalsPerforming creditInspection co operation schemePiramal alternativesNasal spraysPerforming credit fund

Piramal Group s subsidiary invests Rs 110 crore in Biodeal Pharma to strengthen its infrastructure and capacities - Pharma News

Piramal Group s subsidiary invests Rs 110 crore in Biodeal Pharma to strengthen its infrastructure and capacities - Pharma News
financialexpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialexpress.com Daily Mail and Mail on Sunday newspapers.

United statesKalpesh kikaniAnurag kumarBiodeal pharmaceuticalsDrug administrationPiramal group onPiramal alternative performing credit fundPiramal groupPiramal alternativesPiramal alternative performing creditUnited states food

Piramal Alternatives invests ₹110 crore in contract manufacturer Biodeal Pharmaceuticals

Piramal Alternatives invests ₹110 crore in contract manufacturer Biodeal Pharmaceuticals
thehindubusinessline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thehindubusinessline.com Daily Mail and Mail on Sunday newspapers.

Anurag kumarKalpesh kikaniBiodeal pharmaceuticals ltdCredit fundPiramal groupDrug administrationPiramal alternativesPerforming credit fundBiodeal managing director

Piramal Group arm invests Rs 110 crore in Biodeal Pharma

The contract development and manufacturing company will deploy the funds infused by Piramal Alternatives for improving its infrastructure and capacities, technology upgrade and a nutraceuticals manufacturing facility, as per an official statement.

United statesAnurag kumarKalpesh kikaniBiodeal pharmaPiramal group onPiramal groupPiramal alternative performing credit fundBiodeal pharmaceuticalsDrug administrationPiramal alternativesUnited states food

Piramal Enterprises : Alternatives invests INR 110 Cr in Biodeal Pharmaceuticals -April 08, 2024 at 05:04 am EDT

PRESS RELEASE Piramal Alternatives invests INR 110 Cr. in Biodeal Pharmaceuticals The strategic investment will fuel Biodeal s development.

Kalpesh kikaniAnurag kumarCredit fundPiramal groupBiodeal pharmaceuticalsPiramal alternativesBiodeal pharmaceuticals limitedPerforming creditNasal sprays

vimarsana © 2020. All Rights Reserved.